Board Member
CEO & Founder, Daré Bioscience

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in capital formation, business development, and commercial leadership. Highlights from her 20+ year career include: $170M equity raises, a business development deal sheet comprised of in-license, out-license, and M&A, and executing numerous successful product launches.   Sabrina’s unique background spans finance, global marketing, product development and bench research.

Sabrina is committed to advancing innovations in women’s health. In 2015 she founded DARÉ Bioscience, where she currently serves as President and CEO, to bring novel products that clearly address unmet needs to the clinic so that the latest concepts in women’s health make it to market.

Prior to founding DARÉ Bioscience, in her role as President of WomanCare Global Trading, which includes WomanCare Global’s US and Global commercial companies, Sabrina was responsible for new innovation, including accessing capital and expanding the global product portfolio in women’s healthcare. WomanCare Global is a specialty pharmaceutical company in the female reproductive healthcare space with commercial product distribution in over 100 countries.

Sabrina also previously served as the CFO of the California Institute for Biomedical Research and was formerly a key member of the executive management team at Cypress Bioscience, Inc. (NASDAQ:CYPB) where she most recently served as Chief Operating Officer and Chief Financial Officer. At Cypress, she executed mergers, acquisitions, divestitures, strategic partnerships, and capital raises (~$170 million), managed investor relations and commercial organizations, launched 4 products, and oversaw competitive analysis and market opportunity assessment and planning. She was part of the transaction team that negotiated a 160% premium for Cypress shareholders with a deal valued over $250 million.

Sabrina has also provided executive advisory services to clients in the biotechnology, pharmaceutical, and diagnostic industries. Clients included: HUYA Bioscience International (COO, CFO); Kyalin Biosciences, Inc. (Secretary, Treasurer – sale of company); WomanCare Global (CFO); Ridge Diagnostics (business development); 1798 Consultants (marketing strategy); Ocera Therapeutics, Inc. (international brand strategy); Algynomics, Inc. (business plan, funding strategy).

She previously held marketing and sales positions with Advanced Tissue Sciences, where she was responsible for global product positioning for 2 product launches and spent a year in technical sales at Clonetics Corporation. She began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program.

In the community, Sabrina is dedicated to organizations that serve women and girls and promote education.  She serves on the Clearity Foundation Board of Directors, YWCA of San Diego County Board of Directors, Athena Board of Directors, Tulane University School of Science & Engineering Board of Advisors, University California San Diego Librarian’s Advisory Board, and Project Concern International Audit Committee. Sabrina is the former Co-President of Women Give San Diego, which funds non-profit organizations serving women & girls in San Diego.

Sabrina has an MIM from the American Graduate School of International Management (Thunderbird) with honors, an MSc. in Biochemical Engineering from the University of London, University College London, and a BSc. in Biomedical Engineering from Tulane University, where she graduated magna cum laude.

Return to Athena Board of Directors